TWiV 859: COVID-19 clinical update #99 with Dr. Daniel Griffin

<p>In COVID-19 clinical update #99, Daniel Griffin discusses Omicron disease severity, neurologic manifestations in children, testing outcomes during multiple infections, boosters improve VE and VD, booster efficacy for ED and UC encounters, vaccines induce cross-protective T cell memory, and indications for monoclonal antibody therapy.C</p> <p>Subscribe (free): <a title= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784" href= "https://podcasts.apple.com/us/podcast/this-week-in-virology/id1176779065">Apple Podcasts</a>, <a href= "https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <h3><strong>Links for this episode</strong></h3> <ul> <li>Omicron <a href= "https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e4.htm?s_cid=mm7104e4_e&ACSTrackingID=USCDC_921-DM74101&ACSTrackingLabel=MMWR%20Early%20Release%20-%20Vol.%2071%2C%20January%2025%2C%202022&deliveryName=USCDC_921-DM74101"> disease severity</a> (MMWR)</li> <li><a href= "https://www.pedneur.com/article/S0887-8994(21)00276-9/fulltext">Neurologic manifestations</a> in children (Pediatric Neurol)</li> <li>Respiratory virus <a href= "https://wwwnc.cdc.gov/eid/article/28/2/21-1727_article">interference</a> (Emerg Inf Dis)</li> <li>Hospitalization by <a href= "https://covid.cdc.gov/covid-data-tracker/#covidnet-hospitalizations-vaccination"> vaccination status</a> (CDC)</li> <li><a href= "https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e3.htm?s_cid=mm7104e3_w"> Third vaccine dose</a> VE (MMWR)</li> <li>Vaccination induces <a href= "https://www.cell.com/cell/fulltext/S0092-8674(22)00073-3#relatedArticles"> cross-reactive T cells</a> (Cell)</li> <li>Limitations for <a href= "https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-limits-use-certain-monoclonal-antibod